Glenmark Life Sciences Dividend
Dividend criteria checks 3/6
Glenmark Life Sciences is a dividend paying company with a current yield of 2.54% that is well covered by earnings.
Key information
2.5%
Dividend yield
59%
Payout ratio
Industry average yield | 0.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | ₹38.43 |
Dividend yield forecast in 3Y | 2.7% |
Recent dividend updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, GLS has been paying a dividend for less than 10 years.
Growing Dividend: GLS's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
Glenmark Life Sciences Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (GLS) | 2.5% |
Market Bottom 25% (IN) | 0.3% |
Market Top 25% (IN) | 1.1% |
Industry Average (Pharmaceuticals) | 0.8% |
Analyst forecast in 3 Years (GLS) | 2.7% |
Notable Dividend: GLS's dividend (2.54%) is higher than the bottom 25% of dividend payers in the Indian market (0.26%).
High Dividend: GLS's dividend (2.54%) is in the top 25% of dividend payers in the Indian market (1.11%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (58.5%), GLS's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (96.9%), GLS's dividend payments are not well covered by cash flows.